Ocuvera LLC
Capital Timeline
Capital this company has received, each line traceable to a primary record. Amounts are obligations, not contract ceilings.
A blank stage means the data is not ingested yet, not that the money stopped there.
Across the lifetime of these contracts, $1.8M has been obligated and $218K paid out. $1.6M has not been disbursed.
Cumulative from contract start through 2026-08-17. The total above covers only the transactions ingested in the tracking window — a different measure.
- National Institutes of Health$809K2
Why It Matters
Not enough signal yet to assess this company's relevance to Japanese firms.
Events
Events used as evidence for Stage / LCI. Facts and interpretation are recorded separately.
OCUVERA LLC — Grant R44NR019556
REFINEMENT OF A DIGITAL MONITORING SYSTEM TO REDUCE RISK OF HOSPITAL ACQUIRED PRESSURE INJURIES - PROJECT SUMMARY/ABSTRACT THE GOAL OF THE PROPOSED SBIR PROJECT IS TO DEVELOP, IMPLEMENT, AND DEMONSTRATE THE FEASIBILITY OF A DIGITAL PRESSURE ULCER MONITORING (DPM) SYSTEM TO REDUCE THE RISK OF HOSPITAL-ACQUIRED PRESSURE ULCERS (HAPIS). HAPIS ARE A COMMON, COSTLY, AND SERIOUS PROBLEM FOR PUBLIC HEALTH. OCUVERA’S DPIM SYSTEM WILL USE DATA FROM THREE-DIMENSIONAL VIDEO PROCESSING AND CUSTOM ALGORITHMS TO DETECT AND PREDICT RISKY PATIENT BEHAVIORS AS WELL AS TO AUTOMATE NURSE RECORD KEEPING RELATED TO HAPIS. DURING PHASE I, ALGORITHMS WERE REFINED, TESTED, AND CUSTOMIZED TO DIFFERENT SUBTLE PATIENT BEHAVIORS THAT ARE RELATED TO RISK OF HAPI DEVELOPMENT. WE IMPLEMENTED THESE ALGORITHMS IN A PROOF-OF-CONCEPT DPIM SYSTEM THAT WAS EVALUATED IN A CLINICAL ENVIRONMENT. DURING PHASE II, WE WILL REFINE EXISTING ALGORITHMS TO ADDRESS CLINICAL FEEDBACK GATHERED DURING PHASE I, COLLECT ADDITIONAL DATA,
Timeline
No timeline articles for this company yet.